RNF5 inhibitor inh-02
|
R651555-50mg
|
|
324579-65-9 |
50mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
RNF5 inhibitor inh-02
|
R651555-25mg
|
|
324579-65-9 |
25mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
RNF5 inhibitor inh-02
|
R651555-10mg
|
|
324579-65-9 |
10mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Rho-Kinase-IN-2
|
R651546-5mg
|
≥99% |
2573071-18-6 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
Rho-Kinase-IN-2
|
R651546-50mg
|
≥99% |
2573071-18-6 |
50mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
Rho-Kinase-IN-2
|
R651546-25mg
|
≥99% |
2573071-18-6 |
25mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
Rho-Kinase-IN-2
|
R651546-10mg
|
≥99% |
2573071-18-6 |
10mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
RDR 02308
|
R651538-5mg
|
|
4155-82-2 |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
RDR 02308
|
R651538-50mg
|
|
4155-82-2 |
50mg
|
¥ 7700.9
|
期货,请咨询 |
阿拉丁 |
RDR 02308
|
R651538-25mg
|
|
4155-82-2 |
25mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
RDR 02308
|
R651538-10mg
|
|
4155-82-2 |
10mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
RDR 02308
|
R651538-100mg
|
|
4155-82-2 |
100mg
|
¥ 12300.9
|
期货,请咨询 |
阿拉丁 |
Ro24-7429
|
R651352-5mg
|
≥99% |
139339-45-0 |
5mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
Ro24-7429
|
R651352-50mg
|
≥99% |
139339-45-0 |
50mg
|
¥ 12000.9
|
期货,请咨询 |
阿拉丁 |
Ro24-7429
|
R651352-25mg
|
≥99% |
139339-45-0 |
25mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
Ro24-7429
|
R651352-10mg
|
≥99% |
139339-45-0 |
10mg
|
¥ 3800.9
|
期货,请咨询 |
阿拉丁 |
Ro24-7429
|
R651352-100mg
|
≥99% |
139339-45-0 |
100mg
|
¥ 18000.9
|
期货,请咨询 |
阿拉丁 |
Revexepride
|
R651348-1mg
|
≥99% |
219984-49-3 |
1mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
RIP1 kinase inhibitor 1
|
R651327-5mg
|
≥99% |
2095515-38-9 |
5mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
RIP1 kinase inhibitor 1
|
R651327-10mg
|
≥99% |
2095515-38-9 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
Ravoxertinib hydrochloride
|
R651307-5mg
|
≥98% |
2070009-58-2 |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
Ravoxertinib hydrochloride
|
R651307-50mg
|
≥98% |
2070009-58-2 |
50mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
Ravoxertinib hydrochloride
|
R651307-2mg
|
≥98% |
2070009-58-2 |
2mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
Ravoxertinib hydrochloride
|
R651307-10mg
|
≥98% |
2070009-58-2 |
10mg
|
¥ 2580.9
|
期货,请咨询 |
阿拉丁 |